Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FLUIMUCIL FORTE 600 mg COMPRIMIDOS EFERVESCENTES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/FLUIMUCIL FORTE 600 mg COMPRIMIDOS EFERVESCENTES

Approved

STANDARD

FLUIMUCIL FORTE 600 mg COMPRIMIDOS EFERVESCENTES

Zambon🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 8, 2025
Approval ID: b1833ba7c9d13e23
Company: Zambon
Type: Standard

Approval Details

Approval Id: b1833ba7c9d13e23
Drug Cima Aemps Name: FLUIMUCIL FORTE 600 mg COMPRIMIDOS EFERVESCENTES
Register Number: 150202
Holder Company Name: Zambon
Marketing Company Name: Difarmed S.L.U.
Authorization Date: 2025-05-08
Dosage Form: COMPRIMIDO EFERVESCENTE
Dose: 600 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Zambon

Active Ingredients

ACETILCISTEINA

600 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 8, 2025

Approval ID

b1833ba7c9d13e23

Type

Standard

Back to CIMA-AEMPS Approvals